{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:24:45Z","timestamp":1790846685898,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"am","delay-in-days":325,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19dk0307083"],"award-info":[{"award-number":["JP19dk0307083"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP16dk0307060"],"award-info":[{"award-number":["JP16dk0307060"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009048","name":"Japanese Society of Clinical Neuropsychopharmacology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.sleep.2021.11.005","type":"journal-article","created":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T02:00:12Z","timestamp":1637546412000},"page":"23-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Hypnotic medication use among inpatients with schizophrenia and major depressive disorder: results of a nationwide study"],"prefix":"10.1016","volume":"89","author":[{"given":"Ryuji","family":"Furihata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rei","family":"Otsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusuke","family":"Numata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Yasui-Furukori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Kashiwagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikaru","family":"Hori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2263-3477","authenticated-orcid":false,"given":"Shinichiro","family":"Ochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Muraoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Onitsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0614-7524","authenticated-orcid":false,"given":"Masahiro","family":"Takeshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akitoyo","family":"Hishimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Nagasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Takaesu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8129-4220","authenticated-orcid":false,"given":"Toshinori","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Asami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3722-7837","authenticated-orcid":false,"given":"Kenichiro","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4228-3208","authenticated-orcid":false,"given":"Junya","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutaka","family":"Ohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Iida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyoshi","family":"Ogasawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayo","family":"Ichihashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Inada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sleep.2021.11.005_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.sleep.2021.05.011","article-title":"Sleep disturbances and cognitive impairment in schizophrenia spectrum disorders: a systematic review and narrative synthesis","volume":"84","author":"Carruthers","year":"2021","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2021.11.005_bib2","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.4088\/JCP.v66n1008","article-title":"Sleep and depression","volume":"66","author":"Tsuno","year":"2005","journal-title":"J\u00a0Clin Psychiatr"},{"key":"10.1016\/j.sleep.2021.11.005_bib3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.pnpbp.2019.01.016","article-title":"Insomnia in patients with schizophrenia: current understanding and treatment options","volume":"92","author":"Robertson","year":"2019","journal-title":"Progress Neuro-psychopharmacol Biol Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.sleep.2021.11.005_bib4","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S1389-9457(08)70010-8","article-title":"Insomnia and depression","volume":"9","author":"Benca","year":"2008","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2021.11.005_bib5","doi-asserted-by":"crossref","first-page":"990","DOI":"10.3389\/fpsyg.2015.00990","article-title":"Preferences for different insomnia treatment options in people with schizophrenia and related psychoses: a qualitative study","volume":"6","author":"Waters","year":"2015","journal-title":"Front Psychol"},{"key":"10.1016\/j.sleep.2021.11.005_bib6","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.sleep.2019.07.016","article-title":"Sleep, suicide behaviors, and the protective role of sleep medicine","volume":"66","author":"Bishop","year":"2020","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2021.11.005_bib7","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.sleep.2021.03.030","article-title":"Insomnia symptoms are associated with metabolic syndrome in patients with severe psychiatric disorders","volume":"83","author":"Zhang","year":"2021","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2021.11.005_bib8","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.sleep.2021.03.005","article-title":"Clinical features of the patients with major depressive disorder co-occurring insomnia and hypersomnia symptoms: a report of NSSD study","volume":"81","author":"Zhao","year":"2021","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2021.11.005_bib9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.schres.2014.10.002","article-title":"The impact of eszopiclone on sleep and cognition in patients with schizophrenia and insomnia: a double-blind, randomized, placebo-controlled trial","volume":"160","author":"Tek","year":"2014","journal-title":"Schizophr Res"},{"key":"10.1016\/j.sleep.2021.11.005_bib10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1055\/s-2007-1014491","article-title":"Double blind, controlled study of the efficacy and safety of alpidem in the treatment of anxiety in schizophrenic in-patients","volume":"23","author":"Minervini","year":"1990","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.sleep.2021.11.005_bib11","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.biopsych.2006.01.016","article-title":"Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder","volume":"59","author":"Fava","year":"2006","journal-title":"Biol Psychiatr"},{"key":"10.1016\/j.sleep.2021.11.005_bib12","first-page":"322","article-title":"Treatment of insomnia in depressed insomniacs: effects on health-related quality of life, objective and self-reported sleep, and depression","volume":"6","author":"McCall","year":"2010","journal-title":"J\u00a0Clinic Sleep Med : JCSM : Off Pub Am Aca Sleep Med"},{"key":"10.1016\/j.sleep.2021.11.005_bib13","first-page":"225","article-title":"Meta-analysis of benzodiazepine use in the treatment of insomnia","volume":"162","author":"Holbrook","year":"2000","journal-title":"CMAJ (Can Med Assoc J)"},{"key":"10.1016\/j.sleep.2021.11.005_bib14","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/jama.2013.193","volume":"309","author":"Buysse","year":"2013","journal-title":"Insomnia. Jama."},{"key":"10.1016\/j.sleep.2021.11.005_bib15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/pcn.13195","article-title":"Does cognitive behavioral therapy for anxiety disorders assist the discontinuation of benzodiazepines among patients with anxiety disorders? A systematic review and meta-analysis","volume":"75","author":"Takeshima","year":"2021","journal-title":"Psychiatr Clin Neurosci"},{"key":"10.1016\/j.sleep.2021.11.005_bib16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1176\/appi.ajp.2016.16030336","article-title":"Hypnotic medications and suicide: risk, mechanisms, mitigation, and the FDA","volume":"174","author":"McCall","year":"2017","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.sleep.2021.11.005_bib17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.genhosppsych.2019.11.008","article-title":"Long-term use of hypnotics: analysis of trends and risk factors","volume":"62","author":"Enomoto","year":"2020","journal-title":"Gen Hosp Psychiatr"},{"key":"10.1016\/j.sleep.2021.11.005_bib18","series-title":"Treatment guideline \u2161: major depressive disorder","author":"JapaneseSocietyofMoodDisorders","year":"2017"},{"key":"10.1016\/j.sleep.2021.11.005_bib19","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/npr2.12193","article-title":"Japanese Society of Neuropsychopharmacology: \"Guideline for Pharmacological Therapy of Schizophrenia.\"","volume":"41","author":"Japanese Society of Neuropsychopharmacology","year":"2021","journal-title":"Neuropsychopharmacol Rep"},{"key":"10.1016\/j.sleep.2021.11.005_bib20","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3109\/15622975.2012.696143","article-title":"World federation of societies of biological psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance","volume":"13","author":"Hasan","year":"2012","journal-title":"World J Biol Psychiatr : Off J World Feder Soc Biol Psychiatry"},{"key":"10.1016\/j.sleep.2021.11.005_bib21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/15622970701227829","article-title":"World federation of societies of biological psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders in primary care","volume":"8","author":"Bauer","year":"2007","journal-title":"World J Biol Psychiatr : Off J World Feder Soc Biol Psychiatry"},{"key":"10.1016\/j.sleep.2021.11.005_bib22","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1001\/archgenpsychiatry.2011.1532","article-title":"Polypharmacy with antipsychotics, antidepressants, or benzodiazepines and mortality in schizophrenia","volume":"69","author":"Tiihonen","year":"2012","journal-title":"Arch Gen Psychiatr"},{"key":"10.1016\/j.sleep.2021.11.005_bib23","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1017\/S146114571000163X","article-title":"Adjunctive benzodiazepine treatment of hospitalized schizophrenia patients in Asia from 2001 to 2008","volume":"14","author":"Tor","year":"2011","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.sleep.2021.11.005_bib24","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3371\/CSRP.5.3.2","article-title":"Concomitant psychotropic medication use during treatment of schizophrenia patients: longitudinal results from the CATIE study","volume":"5","author":"Chakos","year":"2011","journal-title":"Clin Schizophrenia Relat Psychoses"},{"key":"10.1016\/j.sleep.2021.11.005_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/(SICI)1520-6394(1997)6:1<31::AID-DA5>3.0.CO;2-8","article-title":"Fluoxetine and concomitant centrally acting medication use during clinical trials of depression: the absence of an effect related to agitation and suicidal behavior","volume":"6","author":"Wernicke","year":"1997","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.sleep.2021.11.005_bib26","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/NMD.0b013e3181e9daf7","article-title":"Use of benzodiazepines, hypnotics, and anxiolytics in major depressive disorder: association with chronic pain diseases","volume":"198","author":"Liu","year":"2010","journal-title":"J\u00a0Nerv Ment Dis"},{"key":"10.1016\/j.sleep.2021.11.005_bib27","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/pcn.12911","volume":"73","author":"Takaesu","year":"2019","journal-title":"Psychiatr Clin Neurosci"},{"key":"10.1016\/j.sleep.2021.11.005_bib28","series-title":"Unmet needs of patients with major depressive disorder - findings from the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project: a nationwide dissemination, education, and evaluation study","author":"Iida","year":"2020"},{"key":"10.1016\/j.sleep.2021.11.005_bib29","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/npr2.12122","article-title":"Prescription patterns in patients with schizophrenia in Japan: first-quality indicator data from the survey of \"Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)\" project","volume":"40","author":"Ichihashi","year":"2020","journal-title":"Neuropsychopharmacol Reports"},{"key":"10.1016\/j.sleep.2021.11.005_bib30","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/npr2.12173","article-title":"Improvements in the degree of understanding the treatment guidelines for schizophrenia and major depressive disorder in a nationwide dissemination and implementation study","volume":"41","author":"Numata","year":"2021","journal-title":"Neuropsychopharmacol Rep"},{"key":"10.1016\/j.sleep.2021.11.005_bib31","doi-asserted-by":"crossref","first-page":"102744","DOI":"10.1016\/j.ajp.2021.102744","article-title":"Characteristics of discharge prescriptions for patients with schizophrenia or major depressive disorder: real-world evidence from the Effectiveness of Guidelines for Dissemination and Education (EGUIDE) psychiatric treatment project","volume":"63","author":"Hashimoto","year":"2021","journal-title":"Asian J Psychiatr"},{"key":"10.1016\/j.sleep.2021.11.005_bib32","article-title":"Association between the examination rate of treatment-resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study","author":"Yasui-Furukori","year":"2021","journal-title":"Neuropsychopharmacol Reports"},{"key":"10.1016\/j.sleep.2021.11.005_bib33","unstructured":"Ogasawara K NS, Hasegawa N, Nakataki M, et\u00a0al. The subjective assessment of participants in education programs on clinical practice guidelines in the field of psychiatry. in submission.."},{"key":"10.1016\/j.sleep.2021.11.005_bib34","unstructured":"Yamada H MM, Hasegawa N, Miura K, et\u00a0al. Improvement of psychiatrists' clinical behaviors in accordance with the treatment guidelines for schizophrenia and major depressive disorders using the \u2018Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)\u2019 project: nationwide dissemination, education, and evaluation. in submission.."},{"key":"10.1016\/j.sleep.2021.11.005_bib35","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/pcn.12275","article-title":"Psychotropic dose equivalence in Japan","volume":"69","author":"Inada","year":"2015","journal-title":"Psychiatr Clin Neurosci"},{"key":"10.1016\/j.sleep.2021.11.005_bib36","unstructured":"Health NIoP. WHO collaborating centre for drug statistics methodology."},{"key":"10.1016\/j.sleep.2021.11.005_bib37","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/sbr.12096","article-title":"Association of short sleep duration and short time in bed with depression: a Japanese general population survey","volume":"13","author":"Furihata","year":"2015","journal-title":"Sleep Biol Rhythm"},{"key":"10.1016\/j.sleep.2021.11.005_bib38","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.sleep.2006.10.009","article-title":"Use of alcohol and hypnotic medication as aids to sleep among the Japanese general population","volume":"8","author":"Kaneita","year":"2007","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2021.11.005_bib39","doi-asserted-by":"crossref","first-page":"310","DOI":"10.12788\/jhm.2739","article-title":"High prevalence of inappropriate benzodiazepine and sedative hypnotic prescriptions among hospitalized older adults","volume":"12","author":"Pek","year":"2017","journal-title":"J\u00a0Hosp Med"},{"key":"10.1016\/j.sleep.2021.11.005_bib40","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/BF03262274","article-title":"Hospitalization as a turning point for sleep medication use in older adults: prospective cohort study","volume":"29","author":"Zisberg","year":"2012","journal-title":"Drugs Aging"},{"key":"10.1016\/j.sleep.2021.11.005_bib41","doi-asserted-by":"crossref","first-page":"869","DOI":"10.5665\/SLEEP.1116","article-title":"Sedative medication use: prevalence, risk factors, and associations with body mass index using population-level data","volume":"34","author":"Vozoris","year":"2011","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2021.11.005_bib42","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1192\/bjp.187.3.243","article-title":"Polypharmacy and excessive dosing: psychiatrists' perceptions of antipsychotic drug prescription","volume":"187","author":"Ito","year":"2005","journal-title":"Br J Psychiatry : J Ment Sci"},{"key":"10.1016\/j.sleep.2021.11.005_bib43","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.4088\/JCP.v69n1003","article-title":"Patterns of atypical antipsychotic subtherapeutic dosing among Oregon Medicaid patients","volume":"69","author":"Hartung","year":"2008","journal-title":"J\u00a0Clin Psychiatr"},{"key":"10.1016\/j.sleep.2021.11.005_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198363","article-title":"Patterns and predictors of off-label prescription of psychiatric drugs","volume":"13","author":"Vijay","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.sleep.2021.11.005_bib45","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1001\/jamainternmed.2019.1196","article-title":"An implementation guide to promote sleep and reduce sedative-hypnotic initiation for noncritically ill inpatients","volume":"179","author":"Soong","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.sleep.2021.11.005_bib46","first-page":"1","article-title":"The influence of prescriber and patient gender on the prescription of benzodiazepines: results from the Florida Medicaid Dataset","author":"Lui","year":"2021","journal-title":"CNS Spectr"},{"key":"10.1016\/j.sleep.2021.11.005_bib47","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1192\/bjp.bp.111.101485","article-title":"Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugs","volume":"200","author":"Peluso","year":"2012","journal-title":"Br J Psychiatry : J Ment Sci"},{"key":"10.1016\/j.sleep.2021.11.005_bib48","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1017\/S1461145711000563","article-title":"Adjunctive mood stabilizer treatment for hospitalized schizophrenia patients: asia psychotropic prescription study (2001-2008)","volume":"14","author":"Sim","year":"2011","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.sleep.2021.11.005_bib49","series-title":"Principles and practice of sleep medicine","first-page":"1370","article-title":"Schizophrenia","author":"Benson","year":"2017"},{"key":"10.1016\/j.sleep.2021.11.005_bib50","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/JCP.0b013e31822bb1d9","article-title":"A\u00a0pilot study of the efficacy and safety of paroxetine augmented with risperidone, valproate, buspirone, trazodone, or thyroid hormone in adult Chinese patients with treatment-resistant major depression","volume":"31","author":"Fang","year":"2011","journal-title":"J\u00a0Clin Psychopharmacol"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945721005542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945721005542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T19:25:18Z","timestamp":1778613918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945721005542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":50,"alternative-id":["S1389945721005542"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2021.11.005","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypnotic medication use among inpatients with schizophrenia and major depressive disorder: results of a nationwide study","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2021.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}